Historian and Harvard professor Anne Harrington believes that pharmaceutical companies have played an oversized role in determining how mental illness is treated in the United States — leading to a ...

Drug policy has been a key issue in the race between Pennsylvania Lt. Gov. John Fetterman and Dr. Mehmet Oz for the state’s open U.S. Senate seat, elevating the focus of the candidates’ records on ...

As healthcare venture capitalists, we specialize in technologies that have the potential to transform large markets in healthcare. Earlier this year, we predicted that 2018 would be a year of venture ...

Researchers from the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) designed an experiment to test whether performing X-ray crystallography imaging using elevated temperature ...

While drug makers have discretion over how to price their products, they are clearly responsive to the incentives they face. In a new paper, we study whether the incentives from one major public ...

Scientists have discovered the internal shape of tiny drug-delivery particles - called lipid nanoparticles - has a big impact on how well our cells absorb them, paving the way to more efficient ...

In the United States, drug-resistant bacteria and fungi infect almost three million people per year and kill about 35,000. Antibiotics are essential and effective. However, in recent years overuse has ...

Scientists have developed a new "shape-shifting" antibiotic to fight drug-resistant bacteria, but it hasn't been tested in humans yet. When you purchase through links on our site, we may earn an ...

As the Trump administration begins to shape its policy on drugs, tension is growing between a treatment-focused approach, embodied in a new commission on opioids headed by New Jersey Gov. Chris ...

Reporting from Washington — Donald Trump and his congressional allies are making big plans to repeal the Affordable Care Act and overhaul other government health programs. But the president-elect ...